My research centers around whole blood clots acting as highly viable bioscaffolds with the ability to act as therapetuic delivery systems as well for wound healing and engraftment procedures.  I am wondering how IHC can be performed on sections of blood clots that are FFPE.

More Branden Casey Brown's questions See All
Similar questions and discussions